CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2340-2348

  Aldrich, Melinda C ^a   Selvin, Steve ^b   Hansen, Helen M ^a   Barcellos, Lisa F ^b   Wrensch, Margaret R ^a   Sison, Jennette D ^a   Kelsey, Karl T ^c   Buffler, Patricia A ^b   Quesenberry Jr , Charles P ^d   Seldin, Michael F ^e   Wiencke, John K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BROWN UNIVERSITY   (United States)

^d DIVISION OF RESEARCH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYP1A2 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ALLELE; AMERICAN INDIAN; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENDER; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ENZYMOLOGY; EPIDEMIOLOGY; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETICS; LUNG TUMOR; MIDDLE AGED; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CALIFORNIA; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; FEMALE; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 65549122189     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2576     Document Type: Article

References (38)

1. Corehero j, Pímprale S, Kimura S, Gonzalez Fj. Organization of the CYP1A cluster on human chromo-some 15: implications for gene regulation. Pharmaco-genetics 2001;11:1-6.
2. Nebert DW, Dalton TP, Okey AB, Gonzalez Fj. Role of aryl hydrocarbon receptor-medíated inductíon of the CYP1 enzymes in envíronmental toxìcíty and cancer, j Biol Chem 2004;279:23847-50.
3. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6: 947-60.
4. Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg 2006; 391:603-13.
5. Bernauer U, Heinrich-Hirsch B, Tonníes M, Peter- Matthias W, Gundert-Remy U, Characterìsation of the xenobiotic-metabolizing cytochrome P450 expression pattern in human lung tissue by immunochemícal and activity determination. Toxìcol Lett 2006;164:278-88.
6. Wei C, Caccavale RJ, Kehoe jj, Thomas PE, Iba MM. CYP1A2 Is expressed along with CYP1A1 in the human lung. Cancer Lett 2001;171:113-20.
7. Ghotbi R, Chrístensen M, Roh HK, Ingelman-Sundberg M, Aklíllu E, Bertilsson L. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the geno- type-phenòtype relationship in Swedes and Koreans. Eur jClín Pharmacol 2007;63:537-46.
8. McLemore TL, Adelberg Ss Líu MC, et al. Expression of CYP1A1 gene ìn patíents wíth lung cancer: evídence for cigarette smoke-índuced gene expression In normal lung tìssue and for altered gene regulatíon in prìmary pulmonary carcinomas, J Mat Cancer Inst 1990;82: 1333-9.
9. Wooding SP, Watkins WS, Bamshad MJ, Dunn DM, Weiss KB, jorde LB. DKA sequence variation in a 3.7-kb noncodìng sequence 5́ of the CYP1A2 gene: ìmplicatìons for human population hístory and natural selectìon. Am J Hum Genet 2002;71:528-42.
10. Jíang Z, Dalton TP, Jìn L, et al. Toward the evaluatìon of function in genetic varǐabilitý: characterízing human SNP frequencíes and establíshing BAC-transgenìe mìce carrying the human CYP1A1-CYP1A2 locus. Hum Mutat 2005;25:196-206.
11. Cosma G, Crofts F, Curtie D, Wirgin I, Tonìolo P, Garte Sj. Racíal differences in restriction fragment length polymorphísms and messenger RNA inducìhilìty of the human CYP1A1 gene. Cancer Epidemiol Bio- markers Prev 1993;2:53-7.
12. Shields PG, Caporaso NE, Falk RT, et al. Lung cancer, race, and a CYP1A1 genetic polymorphísm. Cancer Epidemiol Biomarkers Prev 1993;2:481-5.
13. Cote ML, Wenzlaff AS, Bock CH, et al. Combínatìons of cytochrome P-450 genotypes and rǐsk of early-onset, lung cancer ín Caucasìans and Afrìcan Amerìcans: a population-based study. Lung Cancer 2007;55:255-62.
14. Wenzlaff AS, Cote ML, Bock CH, et al. CYP1A1 and CYP1B1 polymorphǐsms and rǐsk of lung cancer among never smokers; a population-based study. Carcinogenesìs 2005;26:2207-12.
15. Wrensch M, Mííke R, Sǐson J, et al. CYP1A1 varìants and smoking-related lung cancer ín San Francisco Bay area Latìnos and Afrìcan Amerícans. Int J Cancer 2005; 113:141-7.
16. Ishibe N, Ŵiencke JK, Zuo ZF, McMíllan A, Spíte M, Kelsey RT. Susceptibility to lung cancer in líght smokers assocìated wìth CYP1A1 polymorphisms in Mexican- arid Afrícan-Americans. Cancer Epìdemìol Bìomarkers Prev 1997;6:1075-80.
17. Thomas DC, Wítte JS. Poínt: populatìon stratìfication: a problem for case-control studîes of candìdate-gene associatíons? Cancer Epídemíol Biomarkers Prev 2002; 11:505-12.
18. Wacholder S, Rothman N, Caporaso M. Counter-point: bias from populatìon stratífìcation Is not a major threat to the valídìty of conclusìons from epidemìological studies of common polymorphisms and cancer. Cancer Epìdemîol Biomarkers Prev 2002; 11:513-20.
19. Hansen HM, Wiemels JL, Wrensch M, Wìencke JK. DMA quantification of whole genome amplìfied samples for genotyping on a multiplexed bead array platform. Cancer Epìdemìol Bíomarkers Prev 2007;16: 1686-90.
20. The International HapMap Consortíum. The Inter-natíonal HapMap Project. Nature 2003;426:789-96.
21. Packer BR, Yeager M, Staats B, et al. SNPSOOCancer: a publìc resource for sequence val̀idatíon and assay development for genetic variat́ion in candidate genes. Nucleic Acids Res 2004;32:D528-32.
22. Tían C, Hinds DA, Shiǵeta R, Kíttles R, Ballínger DG, Seldin MF. A genomewide single-nucleolide- polymorphísmpanel with hígh ancestry ínformation for Afrìcan Amerǐcan admíxture mappìng. Am j Hum Genet 2006; 79:640-9.
23. Tían C, Hínds DA, Shìgeta R, et al. A genomewìde sìngle-nucleotíde-polymorphism panel for Mexican Amerícan admixture mapping. Am j Hum Genet 2007; 80:1014-23.
24. Weîr BS, Cockerham CC. Estìmatìng F-statìstiacute;cs for the analysis of populatítructure. Evolution 1984;38: 1358-70.
25. abríel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
26. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: analysis and vìsualizatíon of LD and haplotype maps. Bioinformatics 2005;21:263-5.
27. Kraft P, Cox DG, Paynter RA, Hunter D, De Vivo I. Accountíng for haplotype uncertaìnty ín matched association studíes: a comparíson of simple and flexible techníques. Genet Epidemíol 2005;28:261-72.
28. Chakraborty R, Weiss KM. Frequencǐes of complex diseases in hybriacute;d populations. Am j Phys Anthropol 1986;70:489-503.
29. Chakraborty R. Gene admixture In human populations: models and predíctions. Yearb Phys Anthropol 1986;29:1-43,
30. Hanìs CL, Chakraborty R, Ferrell RE, Schull WJ, Individual admixture estímates: disease associations and ̀indívì dual rísk of dìabetes and gallbladder dìsease among Mexican-Amerìcans in Starr County, Texas. Am J Phys Anthropol 1986;70:433-41.
31. Benjamíní Y, Hochberg Y, Controllìng the false dìscovery rate: a practícal and powerful approach to multiple testíng, j R Statìst Soc B 1995;57:289-300.
32. Vineis P. Molecular epidemíology: low-dose carci-nogens and genetìc susceptíbílity. Int J Cancer 1997; 71:1-3.
33. Jiang Z, Dragin N, Jorge-Nebert Lis et al. Search for an assocìatíon between the human CYP1A2 genotype and CYP1A2 metabolic phenotype. Pharmacogenet Genomícs 2006;16:359-67.
34. Aklillu E, Carríllo JA, Makonnen E, et al. Genetic polymorphísm of CYP1A2 in Ethiopians affectíng inductíon and expression; characterization of novel haplotypes with sìngle- nucleotíde polymorphísms ín íntron 1. Mol Pharmacol 2003;64:659-69,
35. Pavanello Ss Pulliero A, Lupi S, Gregorio P, Clonfero E. Influence of the genetìc polymorphìsm ín the 5- noncodíng regìon of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity ín smokers. Mutat Res 2005;587:59-66.
36. Saehse C, Rroekmoller J, Bauer S, Roots I. Functional sìgníficance of a C-A polymorphîsm în întron 1 of the cytochrome P450 CYP1A2 gene tested with caffeíne. Br J Clín Pharmacol 1999;47:445-9.
37. Lìn PI, Vance JM, Perîcak-Vance MA, Martín ER. No gene is an island: the flǐp-flop phenomenon. Am J Hum Genet 2007;80:531-8,
38. Wacholder S, Rothman N, Caporaso N. Populatíon stratification in epidemíologic studíes of common genetìc varìants and cancer: quantíficatíon of bias, J Natl Cancer Inst 2000;92:1151-8.